Lab

FMOL Health and Orion Laboratories have announced a joint venture partnership aimed at expanding access to laboratory services across Louisiana. Under the agreement, the two Louisiana-based organizations will combine FMOL Health’s integrated regional care network and clinical expertise with Orion…

Southfield, Mich.-based Corewell Health and Secaucus, N.J.-based Quest Diagnostics have finalized a lab joint venture and hospital lab management agreement. Five things to know: 1. The new joint venture, Diagnostic Lab of Michigan, will be 51% owned by Quest and…

Laboratory and diagnostics companies are urging Congress to halt Medicare reimbursement cuts for hundreds of clinical tests set to take effect Jan. 31. CMS plans to implement up to 15% reductions to Medicare payments for about 800 clinical laboratory tests,…

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay results—driving repeat visits, misdiagnosis, and unnecessary empiric antibiotic use. The result is higher…

Do you worry your clinical laboratory is falling behind in the race to adopt artificial intelligence (AI) technologies? Every day, labs are inundated with media and marketing messages about artificial AI and its potential to transform laboratory medicine. How can…

In healthcare — and specifically, clinical diagnostics — no single organization has unlimited resources. That’s why collaboration is essential for investing in diverse areas to make groundbreaking tools for diagnosis and treatment available to clinicians and the patients they serve.…

Innovation in clinical diagnostics is accelerating, with breakthroughs that promise to make testing more precise, less invasive and more accessible. These advancements are expected not only to benefit patients directly but also enhance the efficiency and value of care delivery…

The FDA has opted to not appeal a federal court decision that struck down the agency’s rule to regulate laboratory-developed tests as medical devices.  The 60-day window for appeal has passed, effectively eliminating the rule that aimed to increase oversight…

Beginning June 2, the Joint Commission will start giving laboratories advance notice of scheduled survey activity. Advance notification will be provided up to 14 days ahead of scheduled survey activity. The change is based on feedback from accredited organizations and…

The FDA cleared the first blood test intended to help in diagnosing Alzheimer’s, marking a significant step in making diagnosis more accessible and less invasive.  The test is designed for adults 55 and older who are showing signs or symptoms…